About NFIL
NFIL is a company based in Mumbai (India) founded in 1967. The company has 2,670 employees as of March 31, 2024. NFIL operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, Liverpool ChiroChem, SpiroChem and IRBM, among others.
- Headquarter Mumbai, India
- Employees 2670 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Navin Fluorine International Limited
-
Annual Revenue
$273.19 M (USD)13.6as on Mar 31, 2025
-
Net Profit
$33.83 M (USD)6.68as on Mar 31, 2025
-
EBITDA
$61.8 M (USD)32.49as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
2670
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of NFIL
NFIL is a publicly listed company on the NSE with ticker symbol NAVINFLUOR in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of NFIL
Unlock access to complete
Funding Insights of NFIL
Detailed funding history for NFIL
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NFIL
Investment portfolio details for NFIL
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NFIL
Detailed financials for NFIL
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nfil Comparisons
Peer comparison for NFIL
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NFIL
NFIL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, Liverpool ChiroChem, SpiroChem and IRBM, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
|
|
| Locked | Locked | Locked |
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
|
|
| Locked | Locked | Locked |
Small organic molecules are supplied for biotech and pharmaceutical R&D.
|
|
| Locked | Locked | Locked |
Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry
|
|
| Locked | Locked | Locked |
Integrated drug discovery and preclinical development services are provided.
|
|
| Locked | Locked | Locked |
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
|
Detailed competitors of NFIL
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nfil
Complete news archive for NFIL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NFIL
NFIL was founded in 1967.
NFIL is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Mar 31, 2024, the latest employee count at NFIL is 2,670.
Annual revenue of NFIL is $273.19M as on Mar 31, 2025.
Navin Fluorine International Limited (NFIL) is a CRAMS company engaged in the research and synthesis of fluorinated compounds for the pharmaceutical, agrochemical and speciality chemical industries. The companys service portfolio includes basic research, library syntheses, process development, scale-up and small and large batch manufacturing. The company has a portfolio of over 27000 compounds and over 3000 IP protected compounds through Manchester Organics, its UK subsidiary. NFILs custom synthesis services are offered mainly through its UK subsidiary Manchester Organics. The company claims to have experience in developing fluoro similars and various fluorochemical analogues of lead compounds and libraries. They offer custom synthesis and contract research services through both FFS and FTE arrangements. NFIL has a cGMP manufacturing facility in India, to cater to mg - ton scale requirements.
NFIL's top competitors include Sai Life Sciences, Acies Bio and Liverpool ChiroChem.
Yes, NFIL is publicly traded on NSE under the ticker symbol NAVINFLUOR.
The ticker symbol of NFIL is NAVINFLUOR on NSE.